Cargando…
Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience
During past years, the increasing knowledge of molecular mechanisms of inflammatory bowel disease (IBD) have led to the development of several targeted biological therapies. This great expansion of available medical options has prompted the need for comparative data between drugs. For years, given t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111554/ https://www.ncbi.nlm.nih.gov/pubmed/33995582 http://dx.doi.org/10.1177/17562848211010668 |